AzTrials
AzTrials

Zygomatic FracturesNCT07044258

Trans-tarsal Stair-step Lateral Extension of the Transconjunctival Approach

A study testing trans-tarsal stair-step lateral extension of the transconjunctival approach and transconjunctival approach in people with Zygomatic Fractures and Lower Eyelid Entropion, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Open reduction and internal fixation of orbito-zygomaticomaxillary complex (OMC) fractures has challenging impact on the selection of suitable surgical approach to orbital and zygomatic skeleton. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Zygomatic Fractures, Lower Eyelid Entropion
What is being tested?
trans-tarsal stair-step lateral extension of the transconjunctival approach and transconjunctival approach
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
1 Oct 2024to 15 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with OMC fractures that require open reduction with internal fixation.
  • Patients with orbital wall defects.
  • Patients with blow out fractures.
  • Adult patient between 18 and 60 years with no gender predilections.

Who cannot join

  • Existing lacerations in the inferior and lateral periorbital regions.
  • Comminuted fracture with bone loss.
  • Existence of infection at the fracture line.
  • Presence of acute or chronic conjunctival diseases.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Alexandria University

    Alexandria, Alexandria Governorate, 21523

Other trials in Egypt

About this study

Official title: Trans-tarsal Stair-step Lateral Extension of the Transconjunctival Approach Versus Transconjunctival Approach in the Management of Orbito-zygomaticomaxillary Complex Fractures (Randomized Controlled Clinical Trial)

Open reduction and internal fixation of orbito-zygomaticomaxillary complex (OMC) fractures has challenging impact on the selection of suitable surgical approach to orbital and zygomatic skeleton. Precise repair of the OMC fractures needs a quite understanding of the regional anatomy, precise diagnosis, an accessible exposure and an accurate rigid fixation of fracture to restore the normal form. The esthetic results are one of the most important requirements for this incision in the facial fracture reduction. conventional approaches to the infraorbital rim/orbital floor include (subciliary mid lower eyelid, or subtarsal) and infraorbital incisions. A thorough understanding of each incisional technique requires an appreciation of the relevant anatomy putting in considerations the risk of associated complications. Transconjuctival incision has a lot of advantages, among which is the production of non-visible scar with low incidence of post -operative ectropion and limited access. Trans-tarsal stair-step lateral extension of the transconjunctival approach provides excellent surgical exposure of OMC fractures avoiding the use of a second incision in the area of zygomatic frontal suture. This technique provides good exposure and excellent esthetics.

the aim of this study is to compare Trans-tarsal Stair-Step Lateral Extension of the Transconjunctival approach with transconjunctival approach in the management of orbital and zygomaticomaxillary complex fractures.

Read the detailed description

This study will be made on twenty patients who will undergo fracture repair of the zygomaticomaxillary complex. Post- operative patient evaluation will be performed with specific attention paid towards accessibility, the exposure duration (time from incision till exposure of the field), esthetic appearance, post- operative pain, postoperative edema, orbital movement, wound healing, scarring, infra orbital nerve sensation and the post- operative ocular complications such as ectropion, entropion, enophthalmos, scleral show and corneal abrasion. Post- operative clinical examinations along with radiographic examination will be done to evaluate the position of zygoma and determine the adequacy of fracture reduction.

Being tested
trans-tarsal stair-step lateral extension of the transconjunctival approach, transconjunctival approach
Keywords
Orbito-zygomaticomaxillary Fracture, Transconjunctival Incision, Lower eyelid
Medical subject headings
Zygomatic Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • trans-tarsal stair-step lateral extension of the transconjunctival approachProcedure or surgery

    patients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach

  • transconjunctival approachProcedure or surgery

    patients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach

Study groups in NCT07044258
Study groupRoleWhat they receive
trans-tarsal stair-step lateral extension of the transconjunctival approachActive comparatorpatients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach
Receives: Procedure: trans-tarsal stair-step lateral extension of the transconjunctival approach
transconjunctival approachExperimentalpatients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via transconjunctival approach
Receives: Procedure: transconjunctival approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. exposure duration

    The time taken between performing the incision till exposure of the field will be recorded using a stopwatch.

    Measured: During the surgery

Secondary outcomes (1)
  1. postoperative edema

    The postoperative edema will be categorized subjectively into mild (just noticeable), mild to moderate (more obvious edema without occlusion of palpebral fissure), moderate to severe (edema partially occluding palpebral fissure), and severe (edema totally occluding palpebral fissure).

    Measured: 1.5 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2025
  2. Study start1 Oct 2024
  3. Primary completion30 Mar 2025
  4. Study completion15 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
patients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07044258
Sponsor's protocol ID
Mod-Trans-2/25
Status last verified
Jun 2025
First submitted
19 Jun 2025
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study

Publications

  • Sobhy DE, Dessoky NY, Alryess AM, Noureldin MG. Trans-tarsal stair-step versus transconjunctival approach in orbito-zygomaticomaxillary fractures: a prospective randomized controlled clinical trial. BMC Oral Health. 2026 Jun 17;26(1):1069. doi: 10.1186/s12903-026-08842-1.

    PubMed 42304401

Questions about this trial

What is this clinical trial studying?

A study testing trans-tarsal stair-step lateral extension of the transconjunctival approach and transconjunctival approach in people with Zygomatic Fractures and Lower Eyelid Entropion, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

exposure duration (time frame: During the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07044258, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in